NEW ORLEANS, April 13, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 29, 2018 to file lead plaintiff applications in a securities class action lawsuit against Patterson Companies, Inc. (NasdaqGS:PDCO), if they purchased the Company’s shares between June 26, 2015 and February 28, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Minnesota.
Get Help
Patterson investors should visit us at https://www.claimsfiler.com/cases/view-patterson-companies-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Patterson and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 12, 2018, the Federal Trade Commission disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies to fix the prices of dental products and refuse to offer discounts or service to buying groups representing dental practitioners. Then, on March 1, 2018, the Company revealed dismal financial results for 2018Q3 and the departure of its Chief Financial Officer.
On this news, the price of Patterson’s shares plummeted $7.48 per share, or 23% in one day.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Same sparkle, different story: how lab-grown diamonds are transforming the market
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
World game at war: why some European nations have threatened a World Cup boycott
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Japan Earthquake Disrupts Auto and Chip Supply Chains 



